Measurement of 5-HT 1A receptor density and in-vivo binding parameters of 18Fmefway in the nonhuman primate

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 8, 2012, Pages 1546-1558

  Wooten, Dustin W ^a,b   Hillmer, Ansel T ^a,b   Moirano, Jeffrey M ^a,b   Ahlers, Elizabeth O ^b   Slesarev, Maxim ^b   Barnhart, Todd E ^a   Mukherjee, Jogeshwar ^c   Schneider, Mary L ^d   Christian, Bradley T ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

5 HT 1A; 18F mefway; B max; K D; multiple injection PET

Indexed keywords

MEFWAY FLUORINE F 18; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTERIOR CINGULATE; ARTICLE; BRAIN CORTEX; CEREBELLUM; IN VIVO STUDY; NONHUMAN; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAPHE NUCLEUS; RHESUS MONKEY; TEMPORAL CORTEX;

ANIMALS; BRAIN; FEMALE; FLUORINE RADIOISOTOPES; LIGANDS; MACACA MULATTA; MALE; MODELS, BIOLOGICAL; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PYRIDINES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 84864535033     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.43     Document Type: Article

References (46)

1. Bacopoulos NG, Redmond DE, Roth RH (1979) Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of primate species: effects of ketamine and fluphenazine. J Neurochem 32:1215-8
2. Burnet PWJ, Eastwood SL, Harrison PJ (1997) 3HWAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with 3H8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30:565-74
3. Carson RE, Lang L,Watabe H, Der MG, Adams HR, Jagoda E (2000) PET evaluation of 18FFCWAY, an analog of the 5-HT1A receptor antagonist,WAY-100635. Nucl Med Biol 27:493-7
4. Christian BT, Narayanan T, Shi B, Morris ED, Mantil J, Mukherjee J (2004) Measuring the in vivo binding parameters of 18F-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab 24:309-22
5. Christian BT, Vandehey NT, Floberg JM, Mistretta CA (2010) Dynamic PET denoising with HYPR processing. J Nucl Med 51:1147-54
6. Costes N, Merlet I, Zimmer L, Lavenne F, Cinotti L, Delforge J, Luxen A, Pujol J-F, Le Bars D (2002) Modeling 18FMPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine (1A) receptor concentration with multiinjection. J Cereb Blood Flow Metab 22:753-65
7. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B, Syrota A, Mazière B (1999) Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 19:533-46
8. Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A (2001) Absolute quantification by positron emission tomography of the endogenous ligand. J Cereb Blood Flow Metab 21:613-30
9. Delforge J, Spelle L, Bendriem B, Samson Y, Bottlaender M, Papageorgiou S, Syrota A (1996) Quantitation of benzodiazepine receptors in human brain using the partial saturation method. J Nucl Med 37:5-11
10. Delforge J, Syrota A, Mazoyer BM (1990) Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data. IEEE Trans Biomed Eng 37:653-61
11. Druse MJ, Kuo A, Tajuddin N (1991) Effects of in utero ethanol exposure on the developing serotonergic system. Alcohol Clin Exp Res 15:678-84
12. Farde L, Ginovart N, Ito H, Lundkvist C, Pike VW, McCarron JA, Halldin C (1997) PET-characterization of carbonyl-11CWAY-100635 binding to 5-HT1A receptors in the primate brain. Psychopharmacology 133:196-202
13. Gallezot J-D, Bottlaender MA, Delforge J, Valette H, SabaW, DolléF, Coulon CM, Ottaviani MP, Hinnen F, Syrota A, Grégoire M-C (2008) Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-18Ffluoro-A-85380 and the multiinjection approach. J Cereb Blood Flow Metab 28:172-89
14. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA (1998) Tracer kinetic modeling of the 5-HT1A receptor ligand carbonyl-11CWAY-100635 for PET. Neuroimage 8:426-40
15. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G (1997) Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using 3HWAY-100635 and 11CWAY-100635. Brain Res 745:96-108
16. Holden JE, Doudet DJ (2004) Positron emission tomography receptor assay with multiple ligand concentrations: an equilibrium approach. In: Methods in enzymology (Abelson JN, Simon MI, eds), vol. 385. New York: Academic Press, 169-84
17. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang S-C, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-9
18. Khawaja X, Evans N, Reilly Y, Ennis C, Minchin MCW (1995) Characterization of the binding of 3HWAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain. J Neurochem 64:2716-26
19. Köhler C, Radesäter A-C, Lang W, Chan-Palay V (1986) Distribution of serotonin-1A receptors in the monkey and the postmortem human hippocampal region. A quantitative autoradiographic study using the selective agonist 3H8-OH-DPAT. Neurosci Lett 72:43-8
20. Lang L, Jagoda E, Schmall B, Sassaman M, Magata Y, Eckelman WC (1999) Comparison of F-18 labeled cis and trans 4-fluorocyclohexane derivatives of WAY 100635. J Nucl Med 40:37P-8P
21. Le Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, Hassoun W, Leviel V, Mekhsian P, Weissmann D, Pujol JF, Luxen A, Comar D (1998) High-yield radiosynthesis and preliminary in vivo evaluation of p-18FMPPF, a fluoro analog of WAY-100635. Nucl Med Biol 25:343-50
22. Logan J, Fowler JS, Volkow ND, Ding YS, Wang G-J, Alexoff DL (2001) A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab 21:307-20
23. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-40
24. Logan J, Volkow ND, Fowler JS, Wang GJ, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemann R, Vitkun S (1994) Effects of blood flow on nCraclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010
25. Logan J, Volkow ND, Fowler JS, Wang G-J, Fischman MW, Foltin RW, Abumrad NN, Vitkun S, Gatley SJ, Pappas N, Hitzemann R, Shea CE (1997) Concentration and occupancy of dopamine transporters in cocaine abusers with 11Ccocaine and PET. Synapse 27:347-56
26. Maeda J, Suhara T, Ogawa M, Okauchi T, Kawabe K, Zhang MR, Semba J, Suzuki K (2001) In vivo binding properties of carbonyl-11CWAY-100635: effect of endogenous serotonin. Synapse 40:122-9
27. Mauger G, Saba W, Hantraye P, Dolle F, Coulon C, Bramoulle Y, Chalon S, Grégoire M-C (2005) Multiinjection approach for D2 receptor binding quantification in living rats using 11Craclopride and the b-microprobe: crossvalidation with in vitro binding data. J Cereb Blood Flow Metab 25:1517-27
28. Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ (1996) Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT. Synapse 24:262-72
29. Morris ED, Bonab AA, Alpert NM, Fischman AJ, Madras BK, Christian BT (1999) Concentration of dopamine transporters: to Bmax or not to Bmax? Synapse 32:136-40
30. Morris ED, Christian BT, Yoder KK, Muzic RF (2004) Estimation of local receptor density, B'max, and other parameters via multiple-injection positron emission tomography experiments. In: Methods in enzymology (Abelson JN, Simon MI, eds), vol. 385. New York: Academic Press, 184-213
31. Muzic RF, Christian BT (2006) Evaluation of objective functions for estimation of kinetic parameters. Med Phys 33:342-53
32. Muzic RF, Cornelius S (2001) COMKAT: compartment model kinetic analysis tool. J Nucl Med 42:636-45
33. Muzic RF, Saidel GM, Zhu N, Nelson AD, Zheng L, Berridge MS (2000) Iterative optimal design of PET experiments for estimating b-adrenergic receptor concentration. Med Biol Eng 38:593-602
34. Olsson H, Halldin C, Farde L (2004) Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22:794-803
35. Pike VW, McCarron JA, Lammertsma AA, Osman AA, Hume SP, Sargent PA, Bench CJ, Cliffe IA, Fletcher A, Grasby PM (1996) Exquisite delineation of 5-HT1A receptors in human brain with PET and carbonyl-11C-WAY-100635. Eur J Pharmacol 301:R5-7
36. Poyot T, Condé F, Grégoire M-C, Frouin V, Coulon C, Fuseau C, Hinnen F, Dollé F, Hantraye P, Bottlaender M (2001) Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-18Ffluoro-L-DOPA. J Cereb Blood Flow Metab 21:782-92
37. Rice OV, Gatley SJ, Shen J, Huemmer CL, Rogoz R, DeJesus OT, Volkow ND, Gifford AN (2001) Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice. Neuropsychopharmacology 25:679-89
38. Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J (2006) Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J Nucl Med 47:1697-706
39. Salinas C, Muzic RF, Ernsberger P, Saidel GM (2007) Robust experiment design for estimating myocardial beta adrenergic receptor concentration using PET. Med Phys 34:151-65
40. Spinelli S, Chefer S, Carson RE, Jagoda E, Lang L, Heilig M, Barr CS, Suomi SJ, Higley JD, Stein EA (2010) Effects of early-life stress on serotonin1A receptors in juvenile rhesus monkeys measured by positron emission tomography. Biol Psychiatry 67:1146-53
41. Tai YC, Chatziioanno A, Siegel S, Young J, Newport D, Goble RN, Nutt RE, Cherry SR (2001) Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol 46:1845-62
42. Tokugawa J, Ravasi L, Nakayama T, Lang L, Schmidt KC, Seidel J, Green MV, Sokoloff L, Eckelman WC (2007) Distribution of the 5-HT1A receptor antagonist 18F-FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Eur J Nucl Med Mol Imaging 34:259-66
43. Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT (2010) High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. J Cereb Blood Flow Metab 30:994-1007
44. Wilson AA, Garcia A, Li J, Dasilva JN, Houle S (1999) Analogues ofWAY-100635 as radiotracers for in vivo imaging of 5-HT1A receptors. J Labelled Compd Rad 42:611-20
45. Wooten DW, Hillmer AT, Murali D, Barnhart TE, Schneider ML, Mukherjee J, Christian BT (2011b) An in vivo comparison of cis-and trans-18Fmefway in the nonhuman primate. Nucl Med Biol 38:925-32
46. Wooten DW, Moraino JM, Hillmer AT, Engle JW, DeJesus OT, Murali D, Barnhart TE, Nickles RJ, Davidson R, Schneider ML, Mukherjee J, Christian BT (2011a) In vivo kinetics of 18FMEFWAY: a comparison with 11CWAY-100635 and 18FMPPF in the nonhuman primate. Synapse 65:592-600